New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
Top Cited Papers
- 31 January 2009
- journal article
- practice guideline
- Published by Elsevier BV in European Journal of Cancer
- Vol. 45 (2), 228-247
- https://doi.org/10.1016/j.ejca.2008.10.026
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Individual patient data analysis to assess modifications to the RECIST criteriaEuropean Journal of Cancer, 2009
- Review of Phase II Trial Designs Used in Studies of Molecular Targeted Agents: Outcomes and Predictors of Success in Phase IIIJournal of Clinical Oncology, 2008
- RECIST revisited: A review of validation studies on tumour assessmentEuropean Journal of Cancer, 2006
- Objective Responses in Patients with Malignant Melanoma or Renal Cell Cancer in Early Clinical Studies Do Not Predict Regulatory ApprovalClinical Cancer Research, 2005
- Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysisThe Lancet, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working partyEuropean Journal of Cancer, 1997
- Analyzing the same data in two ways: a demonstration model to illustrate the reporting and misreporting of clinical trials.Journal of Clinical Oncology, 1989
- Criteria of tumor response used in clinical trials of chemotherapy.Journal of Clinical Oncology, 1985
- Reporting results of cancer treatmentCancer, 1981